[ad_1]
There have been rumors for some time about the experimental drug remedy coronavirus. Last Wednesday, US researchers expressed optimism about the experimental drug remedy in the fight against coronavirus. A clinical trial with the drug found evidence of a 30 percent faster recovery.
The efficacy of remedicavir in push injections is tested in some patients participating in clinical trials.
According to BBC Online, Trump said the drug could be used to treat the coronavirus. The CEO of the pharmaceutical company Gilead described the measure as an important first step and will donate 1.5 million vials to Remdesivir.
Vice President Mike Pence said distribution of drugs to hospitals would begin next Monday.
The medicine is mainly made to treat Ebola. The preliminary results of a study of EE. USA From hospitals around the world show that the recovery time of the corrective application has been reduced from 15 to 11 days. For common flu, the effects of the anti-influenza drug Tamiflu are similar.
Anthony S. Fawcett, a leading infectious disease specialist in the United States and director of the National Institute of Allergy and Infectious Diseases in the United States, says the data shows that the positive effects of corrective treatment are clear.
According to the New York Post, President Trump yesterday announced approval of the remediation by Dan O’Dake, CEO of the pharmaceutical company Gilead Science.
Following evidence of the efficacy of this drug as a clinical trial, a remedy was being used in extremely anxious patients. However, after FDA approval, doctors in the United States will be able to prescribe this drug from now on.
In approving the remediation, Trump said he had spoken to the people in charge of the White House Task Force Coronavirus about the use of the drug.
In addition to task force members Anthony Foussi and Deborah Brix, FDO chief Stephen Hahn agreed to approve the drug.
“We are taking the first steps for inpatients,” O’Day said. We want to make sure that these patients receive the correct medication. “
The company had previously announced that it would donate around 1.5 million doses at no cost.
An AFP report says a small-scale trial published last week by the World Health Organization (WHO) found that remediation against the Ebola virus was not effective. Furthermore, in the case of the Kovid-19, which originated in Wuhan, China in December last year, the limited effect of Remdesivir was also noted.
According to a Nature report, remedicivar was one of the first drugs identified in the laboratory that is likely to affect the new SARS-Cov-2 coronavirus responsible for the creation of Covid-19. It interferes with the replication of some viruses, including the SARS-Cove-2 virus, responsible for the current epidemic. The news came a few weeks after the information was leaked and a day after the mixed results of the drug’s clinical trials.
Fawcett said the drug would become a new standard of care for critically ill patients like this study. The drug has not been tested in people with mild illnesses and is currently given by injection in a hospital.
The drug has been approved by the FDA under the emergency capacity to accelerate the production of test drugs, tests, and other medical products for patients during public health crises.
Adequate evidence of safety and efficacy is required to obtain FDA approval of the drug in general. It should be noted that no medications are currently approved for the treatment of coronavirus, and remedicivir will also require formal approval.
The current situation in the United States
Trump wants to open everything quickly to end the blockade situation. Medicines such as remedicivir are believed to be useful in this regard. The New York Times reports that a dozen states returned to normal life yesterday after a temporary stalemate. The first companies to start operating on a large scale since the United States stopped six weeks ago.
Read more
The United States approved the use of corrective measures in an emergency.
The experimental drug remedy is showing the light of hope for crown treatment.
[ad_2]
